CNBC |
New drug shows promise for treating heart disease in diabetes patients
CNBC Johnson & Johnson's type 2 diabetes drug Invokana significantly reduced the risk of serious heart problems in patients with established heart disease or at elevated risk in a pair of large studies, according to data presented at a medical meeting on ... |
Social Plugin